187 related articles for article (PubMed ID: 32760274)
1. Jieduquyuziyin Prescription Suppresses Inflammatory Activity of MRL/lpr Mice and Their Bone Marrow-Derived Macrophages
Ji L; Fan X; Hou X; Fu D; Bao J; Zhuang A; Chen S; Fan Y; Li R
Front Pharmacol; 2020; 11():1049. PubMed ID: 32760274
[TBL] [Abstract][Full Text] [Related]
2. Jieduquyuziyin Prescription-Treated Rat Serum Suppresses Activation of Peritoneal Macrophages in MRL/Lpr Lupus Mice by Inhibiting IRAK1 Signaling Pathway.
Ji L; Hou X; Deng X; Fan X; Zhuang A; Zhang X; Li R
Evid Based Complement Alternat Med; 2019; 2019():2357217. PubMed ID: 31781262
[TBL] [Abstract][Full Text] [Related]
3. Paeoniflorin inhibits activation of the IRAK1-NF-κB signaling pathway in peritoneal macrophages from lupus-prone MRL/lpr mice.
Ji L; Hou X; Liu W; Deng X; Jiang Z; Huang K; Li R
Microb Pathog; 2018 Nov; 124():223-229. PubMed ID: 30149133
[TBL] [Abstract][Full Text] [Related]
4. Jieduquyuziyin Prescription alleviates hepatic gluconeogenesis via PI3K/Akt/PGC-1α pathway in glucocorticoid-induced MRL/lpr mice.
Ji LN; Wu S; Fu DQ; Fang SJ; Xie GQ; Fan YS; Bao J
J Ethnopharmacol; 2022 Feb; 284():114815. PubMed ID: 34763039
[TBL] [Abstract][Full Text] [Related]
5. Paeoniflorin Inhibits LPS-Induced Activation of Splenic CD4
Ji L; Wang S; Wu S; Bao J; Xie G; Zhang Y; Xu L; Lin N; Wang J; Fan Y; Fu D; Dai Q
Evid Based Complement Alternat Med; 2022; 2022():5161890. PubMed ID: 36467552
[TBL] [Abstract][Full Text] [Related]
6. Investigating the Mechanisms of Jieduquyuziyin Prescription Improves Lupus Nephritis and Fibrosis via FXR in MRL/lpr Mice.
Liu J; Ma Q; Sun Q; Luo Q; Wang Y; Wang C; Zhu A; Zhao L; Yin L; Lou J; Dong Y; Qiu P
Oxid Med Cell Longev; 2022; 2022():4301033. PubMed ID: 35855861
[TBL] [Abstract][Full Text] [Related]
7. Jieduquyuziyin prescription enhances CD11a and CD70 DNA methylation of CD4
Huang S; Peng J; Gan Y; Chen L; Zhu Z; Tian F; Ji L; Fan Y; Zhou C; Bao J
J Ethnopharmacol; 2023 Dec; 317():116776. PubMed ID: 37343653
[TBL] [Abstract][Full Text] [Related]
8. Jieduquyuziyin prescription suppresses IL-17 production and Th17 activity in MRL/lpr mice by inhibiting expression of Ca(2+)/calmodulin-dependent protein kinase-4.
Shui B; Xia W; Wen C; Ding X
J Nat Med; 2015 Jul; 69(3):349-57. PubMed ID: 25821132
[TBL] [Abstract][Full Text] [Related]
9. Jieduquyuzishen Prescription Attenuates Renal Fibrosis in MRL/lpr Mice via Inhibiting EMT and TGF-
Wu S; Ji L; Fan X; Fang S; Bao J; Yuan X; Fan Y; Xie G
Evid Based Complement Alternat Med; 2022; 2022():4987323. PubMed ID: 35591863
[TBL] [Abstract][Full Text] [Related]
10. 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice.
Li X; Liu J; Zhao Y; Xu N; Lv E; Ci C; Li X
BMC Nephrol; 2022 Jul; 23(1):243. PubMed ID: 35804318
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
[TBL] [Abstract][Full Text] [Related]
12. PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr mice.
Zhai JX; Zhang ZX; Feng YJ; Ding SS; Wang XH; Zou LW; Ye DQ
Mol Biol Rep; 2012 Jun; 39(6):6763-71. PubMed ID: 22318546
[TBL] [Abstract][Full Text] [Related]
13. Jieduquyuziyin prescription promotes the efficacy of prednisone via upregulating Nrf2 in MRL/lpr kidneys.
Du L; Feng Y; Wang C; Shi X; Wen C; He Z; Zhang Y
J Ethnopharmacol; 2022 Nov; 298():115643. PubMed ID: 36031105
[TBL] [Abstract][Full Text] [Related]
14. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
Su B; Ye H; You X; Ni H; Chen X; Li L
Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016
[TBL] [Abstract][Full Text] [Related]
15. Regulatory effect of IL-38 on NF-κB pathway in systemic lupus erythematosus.
Zhang J; Tabush N; Wei C; Luo L
Immunobiology; 2023 Mar; 228(2):152322. PubMed ID: 36621308
[TBL] [Abstract][Full Text] [Related]
16. MiR-146a relieves kidney injury in mice with systemic lupus erythematosus through regulating NF-κB pathway.
Fu HX; Fan XP; Li M; Liu MJ; Sun QL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):7024-7032. PubMed ID: 31486503
[TBL] [Abstract][Full Text] [Related]
17. Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway.
You Y; Qin Y; Lin X; Yang F; Li J; Sooranna SR; Pinhu L
BMC Nephrol; 2015 Aug; 16():148. PubMed ID: 26310926
[TBL] [Abstract][Full Text] [Related]
18. Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice.
Chen K; Deng Y; Shang S; Tang L; Li Q; Bai X; Chen X
Biomed Pharmacother; 2022 Sep; 153():113433. PubMed ID: 36076550
[TBL] [Abstract][Full Text] [Related]
19. Jieduquyuziyin prescription alleviates SLE complicated by atherosclerosis via promoting cholesterol efflux and suppressing TLR9/MyD88 activation.
He Y; Tian W; Zhang M; Qiu H; Li H; Shi X; Song S; Wen C; Chen J
J Ethnopharmacol; 2023 Jun; 309():116283. PubMed ID: 36898449
[TBL] [Abstract][Full Text] [Related]
20. STING upregulation mediates ferroptosis and inflammatory response in lupus nephritis by upregulating
Chen J; Chen P; Song Y; Wei J; Wu F; Sun J; Xu Z
J Biosci; 2024; 49():. PubMed ID: 38186000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
